All these trials are all designed to improve the accuracy of treatment of prostate cancer particularly with the use of high quality MRI and PET scanning. Professor Stricker is Chief Investigator of these trials. Tom Cusick is helping to coordinate the trials and can be contacted on T.Cusick@garvan.org.au The MAGNIFI trial – This is a […]
New trials about to commence Read More »
Amila Siriwardana, one of Professor Stricker’s fellows, wins the 2019 BJUI Global Prize for the best paper between 1 July 2017 and 30 June 2018. This is a great honour for Dr Siriwardana and is a great credit to all the team working with Professor Stricker and Louise Emmett on the PSMA data. Many other
Best paper published in the BJUI Read More »
Recently European Urology Oncology accepted the publication of the largest focal NanoKnife therapy group in the world. The article: Electroporation as Primary Treatment for Localised Prostate Cancer: A Biopsy-monitored Prospective Cohort. Eur Urol Oncol (2019), https://doi.org/10.1016/j.euo.2019.04.008 looked at 123 patients all with MRI followup and biopsy followup with a minimum of one year follow up.
NanoKnife series published in EUO Read More »
Professor Stricker’s Focal NanoKnife programme expanding throughout Australia, New Zealand, Israel and the Netherlands.
Focal NanoKnife programme Read More »
Professor Stricker was invited recently to present the outcomes of his focal therapy treatment with the NanoKnife at the international annual scientific meeting of the European Association of Urology. Dr Blazevski, one of Prof Stricker’s fellows, presented the results of Stricker’s first 300 cases. The presentation of this data was well received. The same results
International recognition for NanoKnife therapy programme Read More »
Professor Stricker is the first in New South Wales and the third in Australia to achieve this milestone. He began the first robotic programme in New South Wales at St Vincent’s Private in 2006 and has performed almost half of all the cases at St Vincent’s campus. He has also mentored and taught many of
2000 Robot Radical Prostatectomies Read More »
The 4th Friends of Israel Urological Symposium was held in early July in Tel-Aviv. Professor Stricker was an invited to present. Prof. Stricker’s presentation, “New approaches in potency preservation in RALP” was well received.
Prof. Stricker invited to present at 4th FOIU Read More »
Prof Stricker was invited by Hadassah Urology Department to be the keynote speaker for their recent symposium on salvage treatments. In addition to teaching robotic surgery in theatre, he oversaw theatre setup for minimally invasive biopsies, established the MR fusion technology use and instructed the radiation oncology team on the use of brachytherapy. Prof Stricker
Visiting Professor at Hadassah Urology Department, Jerusalem Read More »
Prof Stricker’s unit at St Vincent’s and the Kinghorn Cancer Centre has been appointed the Asia-Pacific region training centre for NanoKnife therapy. Professor Stricker’s team at St Vincent’s Hospital has now been appointed as the Asia-Pacific region training site for the development of NanoKnife treatments. Stricker and his team have now performed over 200 cases. During this period
NanoKnife (IRE) for localised prostate cancer Read More »
Prof Stricker’s team has published the world’s first report of cancer outcomes following focal NanoKnife therapy for focal prostate cancer. This appeared in October’s 2015 edition of Prostate and Prostatic Diseases. Prof Stricker’s is one of the few centres in the world evaluating this technology as focal therapy for localised prostate cancer. This therapy is
Focal Therapy for Prostate Cancer Read More »
Prof Stricker’s team has now presented the results of the key studies on mMRI of the Prostate by invitation in Australia, USA and Europe. His team have demonstrated it’s accuracy but cautions about how long it takes to develop the expertise to develop this accuracy. It has been shown that a negative MRI is 97%
MRI Prostate Imaging Read More »
Minh Tran, one of Prof Stricker’s fellows, recently presented the results at the American meeting on how to select patients for focal therapy using a high-quality multiparametric MRI and transperineal biopsy. It was shown that in appropriate cases one could be confident of patient selection. It was felt that approximately 20% of patients who came
Selection of patients for focal therapy Read More »
Prof Stricker and A/Prof Emmett have recently published a study comparing PSMA PET/CT scan to the more established Choline PET-CT scan. It confirmed that PSMA PET/CT scaning is much more accurate. Prof Stricker is now conducting trials looking at patients with high-risk cancers using this new PET scanning to allow more appropriate therapy, particularly in high-volume,
PSMA PET/CT Scan Accuracy Read More »
Prof Stricker has introduced a new procedure for benign enlargement of the prostate to enable improvement in urinary function without affecting sexual function. The first case was performed at St Vincent’s in April 2015 and all patients were treated as day patients. The treatment involves placing, at the time of cystoscopy, some needle placements to
The UroLift Procedure Read More »
Prof Stricker presented MRI and focal therapy results at the recent American Urological Association Annual Meeting. MRI was the most topical area at this meeting. His results confirmed the accuracy of multiparametric MRI of the prostate in highly experienced hands. Prof Stricker’s results confirmed the accuracy of multiparametric MRI of the prostate in highly experienced
MRI and focal therapy at the recent American Urological Association Read More »
